These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 1736411)

  • 21. [Experience in controlling hog cholera and the use of avirulent dry virus vaccine].
    Zusmanovskiĭ AG; Gnusin IA
    Veterinariia; 1968 Nov; 45(11):44-5. PubMed ID: 5754043
    [No Abstract]   [Full Text] [Related]  

  • 22. Immunization experiments against hog cholera with the bovine viral diarrhoea virus strain Oregon C24V.
    Simonyi E; Biró J
    Acta Vet Acad Sci Hung; 1967; 17(1):55-61. PubMed ID: 4965783
    [No Abstract]   [Full Text] [Related]  

  • 23. [Enhancement of the immune response by aspecific action of vaccine additives in the aerogenic immunization of swine against swine plague].
    Kaden V
    Arch Exp Veterinarmed; 1983 Sep; 37(5):693-701. PubMed ID: 6362602
    [No Abstract]   [Full Text] [Related]  

  • 24. [Study on hog cholera-sine erysipelas combined liver vaccine. I. Experimental preparation of combined live vaccine (author's transl)].
    Eto M; Susumi S; Mishima M; Kobori N; Watanabe S
    Igaku Kenkyu; 1980 Aug; 50(6):490-4. PubMed ID: 7304106
    [No Abstract]   [Full Text] [Related]  

  • 25. Hog cholera: response of pigs vaccinated under field conditions with photodynamically inactivated hog cholera vaccine of tissue culture origin.
    Crawford JG; White EA; Dayhuff TR
    Am J Vet Res; 1968 Sep; 29(9):1761-7. PubMed ID: 5691745
    [No Abstract]   [Full Text] [Related]  

  • 26. Quadruple antigenic epitope peptide producing immune protection against classical swine fever virus.
    Liu S; Yu X; Wang C; Wu J; Kong X; Tu C
    Vaccine; 2006 Nov; 24(49-50):7175-80. PubMed ID: 17050046
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Aerosol vaccination of swine against hog cholera].
    Kushnir AT; Burtsev VI; Bondarenko IM; Zhogololeva SP; Sergeev VA
    Veterinariia; 1970 Oct; 10():50-2. PubMed ID: 5509575
    [No Abstract]   [Full Text] [Related]  

  • 28. CSIRO's 'natural' vaccines.
    Aust Vet J; 1999 Sep; 77(9):558. PubMed ID: 10561787
    [No Abstract]   [Full Text] [Related]  

  • 29. Status of state-federal hog cholera eradication program.
    Wise GH
    J Am Vet Med Assoc; 1966 Jan; 148(1):18-9. PubMed ID: 5947993
    [No Abstract]   [Full Text] [Related]  

  • 30. A DNA vaccine expressing the E2 protein of classical swine fever virus elicits T cell responses that can prime for rapid antibody production and confer total protection upon viral challenge.
    Ganges L; Barrera M; Núñez JI; Blanco I; Frias MT; Rodríguez F; Sobrino F
    Vaccine; 2005 May; 23(28):3741-52. PubMed ID: 15882536
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Efficacy of avirulent drug viral vaccine against hog cholera].
    But'ianov DD; Kos'ko FA
    Veterinariia; 1970 May; 5():71-2. PubMed ID: 5430621
    [No Abstract]   [Full Text] [Related]  

  • 32. [Status of the development and use of hog cholera vaccines].
    Urbaneck D
    Monatsh Veterinarmed; 1971 Oct; 26(20):785-92. PubMed ID: 4943516
    [No Abstract]   [Full Text] [Related]  

  • 33. Hog cholera (European swine fever).
    Dunne HW
    Adv Vet Sci Comp Med; 1973; 17():315-59. PubMed ID: 4202750
    [No Abstract]   [Full Text] [Related]  

  • 34. [Study of the effectiveness of live viral vaccine against strain K hog cholera].
    Kovalenko IaR; Sidorov MA
    Veterinariia; 1972 Jun; 48(6):54-5. PubMed ID: 5081403
    [No Abstract]   [Full Text] [Related]  

  • 35. Candidate multi-peptide-vaccine against classical swine fever virus induced potent immunity with serological marker.
    Dong XN; Chen Y; Wu Y; Chen YH
    Vaccine; 2005 May; 23(28):3630-3. PubMed ID: 15882522
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The use of killed vaccine in Michigan's hog cholera eradication program.
    Quinn JF
    Proc Annu Meet U S Anim Health Assoc; 1964; 68():285-6. PubMed ID: 5217516
    [No Abstract]   [Full Text] [Related]  

  • 37. [Persistent infection with the classical swine fever virus in vaccinated animals: a risk factor?].
    Loeffen W
    Tijdschr Diergeneeskd; 2008 Jun; 133(11):482-4. PubMed ID: 18578143
    [No Abstract]   [Full Text] [Related]  

  • 38. Modified live marker vaccine candidate CP7_E2alf provides early onset of protection against lethal challenge infection with classical swine fever virus after both intramuscular and oral immunization.
    Leifer I; Lange E; Reimann I; Blome S; Juanola S; Duran JP; Beer M
    Vaccine; 2009 Nov; 27(47):6522-9. PubMed ID: 19732859
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Incidence and control of classical swine fever in West Germany].
    Wittmann G; Ahl R; Lorenz RJ
    Arch Exp Veterinarmed; 1987 Nov; 41(6):825-7. PubMed ID: 3502068
    [No Abstract]   [Full Text] [Related]  

  • 40. Comparison of viraemia- and clinical-based estimates of within- and between-pen transmission of classical swine fever virus from three transmission experiments.
    Durand B; Davila S; Cariolet R; Mesplède A; Le Potier MF
    Vet Microbiol; 2009 Mar; 135(3-4):196-204. PubMed ID: 18986777
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.